Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity

Arthritis Research and Therapy

Volumn 10, Issue 3, 2008, Pages

  Karsdal, Morten A ^a   Madsen, Suzi H ^a   Christiansen, Claus ^a   Henriksen, Kim ^a   Fosang, Amanda J ^b   Sondergaard, Bodil C ^a  

^a NORDIC BIOSCIENCE A S   (Denmark)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; AGGRECANASE; ALCIAN BLUE; COLLAGEN TYPE 2; GELATINASE A; GLYCOSAMINOGLYCAN; MATRIX METALLOPROTEINASE; ONCOSTATIN M; PROTEINASE; PROTEOGLYCAN; SOMATOMEDIN C; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CATABOLISM; CELL FUNCTION; CELLULAR DISTRIBUTION; CHONDROGENESIS; COLLAGEN DEGRADATION; COLLAGEN METABOLISM; CONTROLLED STUDY; COW; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLANT; HISTOLOGY; NONHUMAN; PROTEIN DEGRADATION; PROTEOGLYCAN SYNTHESIS; TISSUE REPAIR; ANIMAL; CATTLE; COMPARATIVE STUDY; ENZYME ACTIVATION; ENZYMOLOGY; HUMAN; METABOLISM; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CARTILAGE, ARTICULAR; CATTLE; COLLAGEN TYPE II; ENDOPEPTIDASES; ENZYME ACTIVATION; HUMANS; MATRIX METALLOPROTEINASES; ORGAN CULTURE TECHNIQUES; PROTEOGLYCANS;

EID: 45249093673     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2434     Document Type: Article

References (43)

1. Abramson SB Attur M Yazici Y Prospects for disease modification in osteoarthritis Nat Clin Pract Rheumatol 2006 2 304-312 10.1038/ ncprheum0193 16932709
2. van Meurs JB van Lent PL Holthuysen AE Singer II Bayne EK Berg Van den WB Kinetics of aggrecanase- and metalloproteinase-induced neoepitopes in various stages of cartilage destruction in murine arthritis Arthritis Rheum 1999 42 1128-1139 10.1002/ 1529-0131(199906)42:6<1128::AID-ANR9>3.0.CO;2-2 10366105
3. Karsdal MA Henriksen K Sørensen MG Gram J Schaller S Dziegiel MH Heegaard AM Christophersen P Martin TJ Christiansen C Bollerslev J Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption Am J Pathol 2005 166 467-476 1602325 15681830
4. Behrens F Kraft EL Oegema TR Jr Biochemical changes in articular cartilage after joint immobilization by casting or external fixation J Orthop Res 1989 7 335-343 10.1002/jor.1100070305 2703926
5. Kiani C Chen L Wu YJ Yee AJ Yang BB Structure and function of aggrecan Cell Res 2002 12 19-32 10.1038/sj.cr.7290106 11942407
6. Sondergaard BC Henriksen K Wulf H Oestergaard S Schurigt U Bräuer R Danielsen I Christiansen C Qvist P Karsdal MA Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation Osteoarthritis Cartilage 2006 14 738-748 10.1016/j.joca.2006.01.016 16563811
7. Hui W Rowan AD Richards CD Cawston TE Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo Arthritis Rheum 2003 48 3404-3418 10.1002/art.11333 14673992
8. Cawston TE Curry VA Summers CA Clark IM Riley GP Life PF Spaull JR Goldring MB Koshy PJ Rowan AD Shingleton WD The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint Arthritis Rheum 1998 41 1760-1771 10.1002/1529-0131(199810)41:10<1760::AID-ART8>3.0.CO;2-M 9778217
9. Karsdal MA Sumer EU Wulf H Madsen SH Christiansen C Fosang AJ Sondergaard BC Induction of increased cAMP levels in articular chondrocytes blocks matrix metalloproteinase-mediated cartilage degradation, but not aggrecanase-mediated cartilage degradation Arthritis Rheum 2007 56 1549-1558 10.1002/art.22599 17469134
10. Caterson B Flannery CR Hughes CE Little CB Mechanisms involved in cartilage proteoglycan catabolism Matrix Biol 2000 19 333-344 10.1016/ S0945-053X(00)00078-0 10963994
11. Little CB Flannery CR Hughes CE Mort JS Roughley PJ Dent C Caterson B Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro Biochem J 1999 344 Pt 1 61-68 10.1042/0264-6021:3440061 10548534 1220614
12. Glasson SS Askew R Sheppard B Carito B Blanchet T Ma HL Flannery CR Peluso D Kanki K Yang Z Majumdar MK Morris EA Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis Nature 2005 434 644-648 10.1038/nature03369 15800624
13. Little CB Mittaz L Belluoccio D Rogerson FM Campbell IK Meeker CT Bateman JF Pritchard MA Fosang AJ ADAMTS-1-knockout mice do not exhibit abnormalities in aggrecan turnover in vitro or in vivo Arthritis Rheum 2005 52 1461-1472 10.1002/art.21022 15880348
14. Stanton H Rogerson FM East CJ Golub SB Lawlor KE Meeker CT Little CB Last K Farmer PJ Campbell IK Fourie AM Fosang AJ ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro Nature 2005 434 648-652 10.1038/nature03417 15800625
15. Little CB Meeker CT Hembry RM Sims NA Lawlor KE Golub SB Last K Fosang AJ Matrix metalloproteinases are not essential for aggrecan turnover during normal skeletal growth and development Mol Cell Biol 2005 25 3388-3399 10.1128/MCB.25.8.3388-3399.2005 15798221 1069612
16. Collins-Racie LA Flannery CR Zeng W Corcoran C Annis-Freeman B Agostino MJ Arai M DiBlasio-Smith E Dorner AJ Georgiadis KE Jin M Tan XY Morris EA LaVallie ER ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage Matrix Biol 2004 23 219-230 10.1016/ j.matbio.2004.05.004 15296936
17. Mort JS Flannery CR Makkerh J Krupa JC Lee ER Use of anti-neoepitope antibodies for the analysis of degradative events in cartilage and the molecular basis for neoepitope specificity Biochem Soc Symp 2003 70 107-114 14587286
18. Tang BL ADAMTS: A novel family of extracellular matrix proteases Int J Biochem Cell Biol 2001 33 33-44 10.1016/S1357-2725(00)00061-3 11167130
19. Schaller S Henriksen K Hoegh-Andersen P Søndergaard BC Sumer EU Tanko LB Qvist P Karsdal MA In vitro, ex vivo, and in vivo methodological approaches for studying therapeutic targets of osteoporosis and degenerative joint diseases: How biomarkers can assist? Assay Drug Dev Technol 2005 3 553-580 10.1089/adt.2005.3.553 16305312
20. Oestergaard S Sondergaard BC Hoegh-Andersen P Henriksen K Qvist P Christiansen C Tankó LB Karsdal MA Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: Implications of the time of initiation Arthritis Rheum 2006 54 2441-2451 10.1002/art.22009 16871544
21. Billinghurst RC Wu W Ionescu M Reiner A Dahlberg L Chen J van Wart H Poole AR Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase Arthritis Rheum 2000 43 664-672 10.1002/ 1529-0131(200003)43:3<664::AID-ANR24>3.0.CO;2-D 10728761
22. Billinghurst RC Dahlberg L Ionescu M Reiner A Bourne R Rorabeck C Mitchell P Hambor J Diekmann O Tschesche H Chen J Van Wart H Poole AR Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage J Clin Invest 1997 99 1534-1545 10.1172/JCI119316 9119997 507973
23. Fosang AJ Neame PJ Last K Hardingham TE Murphy G Hamilton JA The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B J Biol Chem 1992 267 19470-19474 1326552
24. Sumer EU Sondergaard BC Rousseau JC Delmas PD Fosang AJ Karsdal MA Christiansen C Qvist P MMP and non-MMP-mediated release of aggrecan and its fragments from articular cartilage: A comparative study of three different aggrecan and glycosaminoglycan assays Osteoarthritis Cartilage 2007 15 212-221 10.1016/j.joca.2006.07.009 16997584
25. Ishikawa T Nishigaki F Christgau S Noto T Mo J From N Minoura K Hirayama Y Ohkubo Y Mutoh S Cartilage destruction in collagen induced arthritis assessed with a new biochemical marker for collagen type II C-telopeptide fragments J Rheumatol 2004 31 1174-1179 15170932
26. Olsen AK Sondergaard BC Byrjalsen I Tanko LB Christiansen C Müller A Hein GE Karsdal MA Qvist P Anabolic and catabolic function of chondrocyte ex vivo is reflected by the metabolic processing of type II collagen Osteoarthritis Cartilage 2007 15 335-342 10.1016/ j.joca.2006.08.015 17045814
27. Studer RK Levicoff E Georgescu H Miller L Jaffurs D Evans CH Nitric oxide inhibits chondrocyte response to IGF-I: Inhibition of IGF-IRbeta tyrosine phosphorylation Am J Physiol Cell Physiol 2000 279 C961-C969 11003576
28. Curtis AJ Devenish RJ Handley CJ Modulation of aggrecan and link-protein synthesis in articular cartilage Biochem J 1992 288 Pt 3 721-726 1131945 1471984
29. Fosang AJ Last K Gardiner P Jackson DC Brown L Development of a cleavage-site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: Detection of fragments in human synovial fluids Biochem J 1995 310 Pt 1 337-343 1135893 7544117
30. Kleiner DE Stetler-Stevenson WG Quantitative zymography: Detection of picogram quantities of gelatinases Anal Biochem 1994 218 325-329 10.1006/ abio.1994.1186 8074288
31. McQuillan DJ Handley CJ Campbell MA Bolis S Milway VE Herington AC Stimulation of proteoglycan biosynthesis by serum and insulin-like growth factor-I in cultured bovine articular cartilage Biochem J 1986 240 423-430 1147434 3545187
32. Fosang AJ Last K Stanton H Weeks DB Campbell IK Hardingham TE Hembry RM Generation and novel distribution of matrix metalloproteinase-derived aggrecan fragments in porcine cartilage explants J Biol Chem 2000 275 33027-33037 10.1074/jbc.M910207199 10882746
33. Oestergaard S Chouinard L Doyle N Karsdal MA Smith SY Qvist P Tankó LB The utility of measuring C-terminal telopeptides of collagen type II (CTX-II) in serum and synovial fluid samples for estimation of articular cartilage status in experimental models of destructive joint diseases Osteoarthritis Cartilage 2006 14 670-679 10.1016/j.joca.2006.01.004 16500121
34. Elders MJ The increasing impact of arthritis on public health J Rheumatol Suppl 2000 60 6-8 11032095
35. Wieland HA Michaelis M Kirschbaum BJ Rudolphi KA Osteoarthritis - an untreatable disease? Nat Rev Drug Discov 2005 4 331-344 10.1038/nrd1693 15803196
36. Stoop R Kraan van der PM Buma P Hollander AP Poole AR Berg Van den WB Denaturation of type II collagen in articular cartilage in experimental murine arthritis. Evidence for collagen degradation in both reversible and irreversible cartilage damage J Pathol 1999 188 329-337 10.1002/ (SICI)1096-9896(199907)188:3<329::AID-PATH371>3.0.CO;2-B 10419604
37. Smeets RL Veenbergen S Arntz OJ Bennink MB Joosten LA Berg Van den WB Loo van de FA A novel role for suppressor of cytokine signaling 3 in cartilage destruction via induction of chondrocyte desensitization toward insulin-like growth factor Arthritis Rheum 2006 54 1518-1528 10.1002/art.21752 16646036
38. Loo van de FA Arntz OJ van Enckevort FH van Lent PL Berg Van den WB Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation Arthritis Rheum 1998 41 634-646 10.1002/ 1529-0131(199804)41:4<634::AID-ART10>3.0.CO;2-1 9550472
39. Glasson SS Askew R Sheppard B Carito BA Blanchet T Ma HL Flannery CR Kanki K Wang E Peluso D Yang Z Majumdar MK Morris EA Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice Arthritis Rheum 2004 50 2547-2558 10.1002/art.20558 15334469
40. Lark MW Bayne EK Flanagan J Harper CF Hoerrner LA Hutchinson NI Singer II Donatelli SA Weidner JR Williams HR Mumford RA Lohmander LS Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints J Clin Invest 1997 100 93-106 10.1172/JCI119526 9202061 508169
41. Lohmander LS Atley LM Pietka TA Eyre DR The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis Arthritis Rheum 2003 48 3130-3139 10.1002/art.11326 14613275
42. Struglics A Larsson S Pratta MA Kumar S Lark MW Lohmander LS Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments Osteoarthritis Cartilage 2006 14 101-113 10.1016/j.joca.2005.07.018 16188468
43. Fan Z Bau B Yang H Soeder S Aigner T Freshly isolated osteoarthritic chondrocytes are catabolically more active than normal chondrocytes, but less responsive to catabolic stimulation with interleukin-1beta Arthritis Rheum 2005 52 136-143 10.1002/art.20725 15641077